As a positive control for this assay we assessed the expression of DOHH, a validated miR-331-3p target in prostate cancer cells [14] and found that DOHH expression was decreased in GBM cells following transfection of miR-331-3p (data not shown). The gene discussed is DOHH; the disease is glioblastoma.